The isolated polycystin-1 cytoplasmic COOH terminus prolongs ATP-stimulated Cl Ϫ conductance through increased Ca 2ϩ entry.
The precise steps leading from mutation of the polycystic kidney disease (PKD1) gene to the autosomal dominant polycystic kidney disease (ADPKD) phenotype remain to be established. Fluid accumulation is a requirement for cyst expansion in ADPKD, suggesting that abnormal fluid secretion into the cyst lumen might play a role in disease. In this study, we sought to establish a link between polycystin-1 (the PKD1 gene product) and ATP-stimulated Cl Ϫ secretion in renal tubule cells. To do this, we performed a whole cell patchclamp analysis of the effects of expression of the isolated cytoplasmic COOH-terminus of polycystin-1 in stably transfected mouse cortical collecting duct cells. The truncated polycystin-1 fusion protein prolonged the duration of ATPstimulated Cl Ϫ conductance and intracellular Ca 2ϩ responses. Both effects were dependent on extracellular Ca 2ϩ . It was determined that expression of the truncated polycystin-1 fusion protein introduced, or activated, an ATP-induced Ca 2ϩ entry pathway that was undetectable in transfection control cell lines. Our findings are concordant with increasing evidence for a role of polycystin-1 in cell Ca 2ϩ homeostasis and indicate that dysregulated Ca 2ϩ entry might promote Cl Ϫ secretion and cyst expansion in ADPKD.
autosomal dominant polycystic kidney disease; purinergic P 2 receptors; chloride channels; kidney collecting tubules; patch-clamp techniques IN THE MAJORITY OF CASES, autosomal dominant polycystic kidney disease (ADPKD) arises as a consequence of loss-of-function mutations in the polycystic kidney disease (PKD1) gene encoding polycystin-1 (11, 20) . The cardinal feature of ADPKD is the gross disruption of normal renal parenchyma by multitudes of cysts.
There is a close correlation between cyst expansion and loss of renal function (13) , probably because cysts replace normal renal parenchyma and distort the renal vasculature as they grow. ATP-stimulated Cl Ϫ secretion may play a role in the accumulation of fluid required for cyst expansion. Stimulation of P2Y 2/4 purinergic receptors by extracellular ATP is a potent stimulus for Cl Ϫ secretion in many epithelial systems, including renal tubule cell epithelia (4, 6, 9) , and is mediated by phospholipase C, increased intracellular Ca 2ϩ ion concentration ([Ca 2ϩ ] i ; see Ref. 39) , and activation of Ca 2ϩ -responsive Cl Ϫ channels (possibly the Cl Ϫ , Ca 2ϩ channel; see Refs. 6 and 14) . All the components for purinergic signal transduction have been identified within the ADPKD cyst, including: 1) expression of P2Y 2 and other purinergic receptors in cyst epithelial cells, 2) ATP release from cyst epithelial cells, and 3) accumulation of ATP in the cyst lumen at micromolar levels (32) . Cyst epithelial cells are responsive to extracellular ATP, which activates transepithelial Cl Ϫ secretion through an increased [Ca 2ϩ ] i (32) . In a previous study, it was shown that expression of the cytoplasmic COOH-terminal 193 amino acids of polycystin-1 (the sIgPKD193 fusion protein) resulted in upregulation of ATP-stimulated transepithelial Cl Ϫ secretion (19) . In the present study, we show that the effect of the fusion protein on transepithelial Cl Ϫ secretion is mediated by an increase in the amplitude and duration of ATP-stimulated Cl Ϫ conductance and that the prolongation of Cl Ϫ conductance is because of an effect of the sIgPKD193 fusion protein to upregulate agonist-stimulated Ca 2ϩ entry. Our observations are the first to demonstrate that polycystin-1 pathways modulate ATP-stimulated Cl Ϫ conductance through effects on Ca 2ϩ entry and provide a plausible link between the genetic lesion and the relentless cyst expansion responsible for loss of renal function in ADKPD.
MATERIALS AND METHODS
Generation of stable cell lines. The M1 mouse cortical collecting duct cell line (33) was selected as the parental source for stable transfections. We have already established that M1 cells express endogenous polycystin-1 mRNA (36) . The sIgPKD193 construct (36) was created by fusion of a membrane expression cassette with the COOH-terminal cytoplasmic domain of murine polycystin-1 (provided by Drs. G. Waltz and G. Germino) and ligated into the glucocorticoidresponsive expression vector pLKNeo (18) . Control lines were generated by stable transfections with the isolated membrane expression cassette (sIg) or vector alone.
For the purpose of this investigation, we used three dexamethasone (Dex)-inducible sIgPKD193-expressing cell lines referred to as clones 2, 18, and 20. Three control lines were created, known as sIg (expressing the membrane expression cassette alone) and p8 and p9 (both derived from vector-alone transfections). These cell lines have been described previously (19, 36) . Expression of the sIgPKD193 fusion protein was evident by Western blot analysis in these cell lines, whereas endogenous full-length polycystin-1 expression was only detectable by prolonged exposure of Northern blot or by RT-PCR. This indicated that the sIgPKD193 fusion protein was probably present in excess over endogenous full-length polycystin-1.
Cell culture. Stably transfected M1 cells were used from passages 2-20 and were handled as already described (36) . In brief, cells were grown on Matrigel-coated glass coverslips and maintained in a 5% CO 2 atmosphere at 37°C in DMEM-F-12 media (GIBCO) supplemented with 5% FCS (GIBCO). Where stated in the text, 1 M Dex was added to the medium to induce fusion protein expression. Cells were seeded at 25,000 cells in 0.5-ml wells; the medium was changed to an FCS-devoid medium after 24 h of growth. Cells were used for electrophysiological and Ca 2ϩ -measurement studies between 2 and 4 days after seeding. In preparation for each experiment, a complete panel of all six lines was seeded in each plate, thereby excluding systematic bias in the growth intervals. Ca 2ϩ -imaging and patch-clamping studies were performed on identical-appearing single cells within clusters of ϳ25 cells. The cell morphology and degree of confluency were therefore no different between cell lines in patch-clamp or Ca 2ϩ -imaging experiments. The cell capacitance measurements showed no difference between patched cells in the electrophysiological studies, indicating that there was no consistent variation in cell size between cell lines. We did not attempt to measure cilia length in these preparations but have noted the presence of apical cilia of similar appearance in all cell lines in separate studies of monolayers grown under identical circumstances.
General experimental design. Cells grown on glass coverslips were superfused (5 or 2 ml/min for patch-clamp or fluorescence studies, respectively) by a continuous-flow system that allowed quick addition and washout. Agonists were added for 10 s in patch-clamp studies and for 20 s in singlecell fluorescence studies and then washed for a period of 10 min in experiments requiring repeated stimulation. The majority of experiments were performed at room temperature, but one experiment was performed at 34 -36°C using a heated stage to confirm that the effect of fusion protein expression on the ATP-stimulated Ca 2ϩ response was evident at physiological temperature.
Patch-clamp technique. The perforated-patch whole cell configuration of the patch-clamp technique was used. To establish the perforated patch, 10 M ␤-escin was added to the pipette solution (12) . An Axopatch 200B patch-clamp amplifier (Axon Instruments) and computer complete with pCLAMP 8.0 software (Axon Instruments) were used to acquire and analyze whole cell currents (I) or membrane voltage. Cells were viewed through the ϫ40 objective of a Nikon inverted microscope. Patch pipettes were pulled from KwikFil glass capillaries (World Precision Instruments) and had a resistance ranging between 3.5 and 4.0 M⍀. The reference electrode was an Ag/AgCl pellet. Current signals were filtered at 5 kHz and displayed on an oscilloscope (20 MHz digital storage, type 1425; Gould). Agonist-activated membrane currents at a holding potential (V h) of Ϫ60 mV were recorded at room temperature (21-23°C).
mRNA extraction. mRNA extraction and RT-PCR methods are as described previously (3) . Briefly, M1 cell monolayers were resuspended in 1 ml TRIzol reagent (GIBCO-BRL) and passed through a pipette several times to ensure a homogeneous suspension. RNA was extracted using TRIzol/chloroform extraction and isopropyl alcohol precipitation according to the manufacturer's protocol. The final pellet was air-dried and resuspended in RNase-free distilled water. RNA concentration and purity were determined by spectrophotometry.
RT-PCR. Specific primers were selected from the sequence of the mouse P2Y 2, P2Y4, and P2Y6 receptor cDNA by using Oligo Primer analysis software (Medprobe, Oslo, Norway). RT-PCR methods were as described previously (3) . Briefly, 1 g total RNA was reverse transcribed for 50 min at 42°C with 0.5 l oligo(dT) 12-18 using a first-strand cDNA synthesis kit for RT-PCR (Superscript II RNase H Ϫ RT; GIBCO-BRL). Negative controls were carried out in the absence of RT. The resulting cDNA template or negative control (10%) was used for PCR amplification with PCR Core System I (Promega, Southampton, UK) following the manufacturer's instructions. For all experiments, denaturation at 95°C for 3 min was followed by 30 cycles of 95°C for 30 s, annealing for 1 min and 72°C for 1 min, and then a final extension step of 72°C for 5 min. PCR products were resolved on a 2% (wt/vol) agarose gel containing 10 g/ml ethidium bromide and visualized under ultraviolet illumination. Images were captured using a Fluor-S Multi-Imager (Bio-Rad). The primer sequences used were as listed as follows: P2Y2, CTTCAAGTACGTGCTGT-TGC (forward) and AGGTGTCATGGCAAGTGATC (reverse); P2Y4, GCTATTCACATCACTAGGTC (forward) and GCAG-TAGAGGTTCCAGTAGA (reverse); P2Y6, GGCTTGTTATT-GTCGCA (forward) and GCCTCTGTAAGAGATCGT (reverse).
The annealing temperatures and product size for each reaction were as follows: P2Y2, 58°C and 470 bp; P2Y4, 58°C and 331 bp; P2Y6, 56°C and 329 bp.
Measurement of [Ca 2ϩ ]i. A spectrofluorometric method with fluo 3-AM (dissolved in DMSO with 20% pluronic acid) as the Ca 2ϩ indicator was used for measurement of [Ca 2ϩ ]i in single cells. Cells were loaded with 10 M fluo 3-AM in DMEM-F-12 medium for 30 min at room temperature (21-23°C). Cells were then washed thoroughly with medium to remove extracellular fluo 3-AM and rested for 30-45 min to allow for complete deesterification of cytosolic dye. Fluo 3-AM was excited at 488 nm with a xenon light source, and fluorescence was measured at 535 nm, recorded, and stored in a computer for data processing and analysis using pCLAMP 8.0 software. Photo bleaching and light-induced damage to cells were minimized by taking short measurements (of 120-ms duration) one time per second over a 200-s period. Studies were performed at room and physiological temperatures. On analysis, fluorescence data for each experiment were normalized to the individual basal fluorescence value to bring all the response curves to the same pretreatment starting point. Equivalent loading of cells was confirmed by incubation with the Ca 2ϩ ionophore A-23187 (10 M) and measurement of fluorescent signal in response to perfusion with a solution containing 10 mM Ca 2ϩ (maximal) and subsequent quenching in 1 M manganese chloride (background). There were no consistent differences between cell lines with respect to the basal fluorescence values or efficiency of loading with fluo-3 AM. Fluorescent signal intensity was attenuated when cells were studied at 34 -36°C, where a down-sloping baseline indicated progressive loss of cytoplasmic dye as the probable explanation. Because of this, single-cell studies were not possible at physiological temperature, and, consequently, groups of ϳ25 cells were imaged in the studies at the warmer temperature to increase the signal-to-noise ratio.
Measurement of Ca 2ϩ influx. To measure Ca 2ϩ influx after a Ca 2ϩ release stimulus, cells were loaded with fluo 3-AM as described above and stimulated with 10 M ATP for 30 s in a zero Ca 2ϩ buffer to prevent refilling of the endoplasmic reticulum (ER) from capacitative Ca 2ϩ entry. Three minutes following exposure to ATP, cells were switched to a buffer containing 2 mM Ca 2ϩ (Ca 2ϩ add-back). In each experiment, a field of ϳ50 cells was imaged continuously. The absolute increase in fluorescent signal on Ca 2ϩ add-back was taken as an indicator of the degree of activation of Ca 2ϩ entry pathways. Because exposure to zero Ca 2ϩ buffer might itself promote Ca 2ϩ entry (7), baseline studies of the effect of transition from zero to normal external Ca 2ϩ were performed. Ca 2ϩ add-back responses are expressed as the peak fluorescent signal minus the value immediately preceding Ca 2ϩ add-back.
Solutions. The standard bath solution was (in mM) 140 NaCl, 5 KCl, 1.8 MgCl 2, 1.8 CaCl2, and 10 HEPES (adjusted to pH 7.45 with NaOH). For the evaluation of fluo-3 AM loading efficiency, the Ca 2ϩ concentration of this buffer was increased to 10 mM. For the zero Ca 2ϩ buffer, Ca 2ϩ was replaced with 0.1 mM EGTA. In patch-clamp experiments, microelectrode pipettes were filled with (in mM) 140 KCl, 1.8 MgCl 2, and 10 HEPES (adjusted to pH 7.4 with KOH and filter sterilized). ␤-Escin (10 M) was added to the final pipette solution. All chemicals and reagents were purchased from Sigma, except for fluo 3-AM, which was obtained from Molecular Probes. Antagonists were preincubated for 10 min before the addition of ATP (ϳEC 70 concentration, 3 M ATP). The reversibility of receptor blockade was tested after a 10-min antagonist-washout period.
Data analysis. For concentration-response curves, data were normalized to the maximum current (I max) evoked by ATP (10 M). The agonist concentration that evoked 50% of the maximum response (EC 50) was taken from Hill plots of the transform, log(I/Imax Ϫ I). Concentration-response curves were fitted by nonlinear regression analysis using commercial software (Prism version 2.0; Graph-Pad). Decay times were calculated as the time for the ATP-induced current or cell Ca 2ϩ response to fall from 80 to 20% of the peak value. Multiple comparisons between the six cell lines were made by one-way ANOVA, with significance accepted at P Ͻ 0.05 by unpaired two-tailed t-test with the Dunnett multiplicity adjustment, using "Instat II" software. Comparison between the two groups of cell lines (control vs. sIgPKD193) was made by unpaired t-test. Data are given as mean values Ϯ SE for n experiments.
RESULTS
Whole cell patch-clamp experiments. ATP elicited a whole cell, inward Ca 2ϩ -activated Cl Ϫ current in voltage-clamped (V h ϭ Ϫ60 mV) M1 mouse cortical collecting duct-derived cell lines. Six cell lines were studied (3 sIgPKD193-expressing cell lines, named clone 2, 18, and 20; and 3 control cell lines named sIg, p8, and p9). After treatment with 1 M Dex, the maximal ATPinduced currents were greater in the sIgPKD193 fusion protein-expressing clones 2, 18, and 20 (P Ͻ 0.005). This effect is shown in representative traces for sIg (control cell line) and clone 18 (sIgPKD193-expressing cell line) in Fig. 1A and summarized in Fig. 1B . In the absence of Dex, peak currents were no different between cell lines. As can be seen in representative whole cell current responses to ATP (Fig. 1A ) and in summary data (Fig. 1C) , expression of the sIgPKD193 fusion protein significantly increased the decay time of ATP-evoked whole cell currents (P Ͻ 0.0001). In the absence of Dex treatment, decay rates were similar in all cell lines. There were no differences between cell lines in activation rates irrespective of treatment with Dex (data not shown).
The ATP concentration-response relationships for clones sIg and 18 were identical in the presence and absence of Dex ( Fig. 2A) , indicating that there was no effect of Dex or fusion protein expression on receptor sensitivity to agonist activation. A range of nucleotide agonists was tested for activity in the control cell line (sIg, plus Dex) and the sIgPKD193 clone (18, plus Dex) to test whether expression of the sIgPKD193 fusion protein resulted in a change in receptor subtype expression (Fig. 2B) . The agonists used were ATP, UTP, 2-methylthio-ATP (2-meSATP), and 2Ј3Ј-O-(4-benzoylbenzoyl)-ATP (BzATP). The potency order for both sIg and 18 (by comparison of EC 50 values) was ATP ϭ UTP Ͼ 2-meSATP Ͼ BzATP. In both cases, 2-meSATP and BzATP were partial agonists. The same results were found in the absence of Dex treatment (data not shown). This pharmacological profile was consistent with the presence of P2Y 2 , P2Y 4 , and/or P2Y 6 receptors (all responsive to uridine compounds). RT-PCR analysis performed on parental M1 cells confirmed expression of mRNA for each of these purinergic receptor subtypes (Fig. 2C) .
The current response to ATP was characterized with respect to the reversal potential and antagonist profile, as shown in Fig. 3, A (6, 9, 31) . ATP-stimulated cell Ca 2ϩ responses are biphasic, with an initial peak resulting from Ca 2ϩ release from the ER, followed by a more prolonged phase resulting from Ca 2ϩ entry from outside the cell (5). The latter component, described as "store-operated" Ca 2ϩ entry, is thought to be triggered by ER Ca 2ϩ store depletion and serves as the means of replenishing these Ca 2ϩ stores (30) . The prolongation of the decay phase of the ATP-stimulated current induced by expression of the sIgPKD193 fusion protein therefore suggested that the by EGTA (0.1 mM) had no effect on control clone sIg but shortened the decay phase of the ATP response to a control configuration in sIgPKD193-expressing clone 18 (Fig.  3C ). This effect was partially reversed after a 10-min washout of EGTA, revealing a biphasic decay of Cl Ϫ current in clone 18. Measurements of [Ca 2ϩ ] i were therefore made to explore the possibility that altered Fig. 1 . Expression of the sIgPKD193 fusion protein resulted in an increase in the peak and duration of the ATPstimulated whole cell Cl Ϫ current response of a cortical collecting duct cell line. A: representative whole cell patch-clamp tracing in Dex-treated cells shows that the amplitude and duration of the whole cell ion flux response to ATP were increased in a cell expressing the sIgPKD193 fusion protein (clone 18) compared with a transfection control cell (sIg). B: in a series of such experiments, peak ion flux in response to ATP was significantly increased (P Ͻ 0.005) by expression of the sIgPKD193 fusion protein in 3 stably transfected cell lines. In the absence of dexamethasone (Dex), peak ion flux was no different between cell lines. Inset shows whole cell capacitance (WCC), which was similar in all cell lines. C: prolongation of the ATP response in cells expressing the sIgPKD193 fusion protein can be clearly seen as an increase in the time taken for decay from 80 to 20% of the ATP-induced peak current (P Ͻ 0.0001). In the absence of Dex, there was no difference in decay time between cell lines. The number of observations for each experiment is as follows (listed as sIg, p8, p9, 2, 18, and 20): Dexϩ: 15, 10, 8, 10, 15, and 5; DexϪ, 8, 6, 6, 6, 6, and 6. I, current. ଙ Significant difference from control. Fig. 2 . Expression of the sIgPKD193 fusion protein had no effect on the pharmacodynamics of the purinergic response. A: whole cell patch-clamp ATP concentration-response curves were the same, irrespective of Dex treatment, in cell lines sIg (control, n ϭ 4) and 18 (which expresses the sIgPKD193 fusion protein in response to Dex, n ϭ 6). B: whole cell patch-clamp agonist concentration-response curves for Dex-treated cell lines sIg and 18 (n ϭ 4, both cell lines) showed that both cell lines responded in similar fashion to a range of purinergic agonists. ] i response to ATP was ] i were also modulated by the addition of PPADS (100 M), where the fluorescence ratio increase was reversibly inhibited by 53.4 Ϯ 9.6% (n ϭ 3) in sIg (ϩDex) and 61.1 Ϯ 12.4% (n ϭ 3) in clone 18 (ϩDex); these values were not significantly different in the absence of Dex. DIDS (100 M) had no effect on [Ca 2ϩ ] i levels in any of the clones, irrespective of Dex treatment (n ϭ 3 for each experimental group, data not shown).
To dissociate Ca 2ϩ release from Ca 2ϩ entry, [Ca 2ϩ ] i was measured on return of Ca 2ϩ to the bath 3 min after stimulation with ATP in zero Ca 2ϩ buffer. The increase in fluorescence signal indicated Ca 2ϩ influx, which was activated by transition from 0 to 2 mM Ca 2ϩ alone in baseline (non-ATP-treated) experiments (Fig. 6A) . Interestingly, prior stimulation of Dex-treated cells with ATP did not increase the Ca 2ϩ influx response above basal in control cells but evoked a significant suprabasal increase in Ca 2ϩ influx in cells expressing the sIgPKD193 fusion protein (Fig. 6 , B and D, P ϭ 0.0052). Control cell line responses were the same in Dex plus vs. Dex minus experiments, whereas the effect of ATP on the Ca 2ϩ entry response in the sIgPKD193 cell lines was reduced (although not completely to control cell line levels) in the absence of Dex (Fig. 6 , B, C, and D, P ϭ 0.048). Peak ATP responses in the absence of Ca 2ϩ were not significantly different in these experiments.
DISCUSSION
In the whole cell patch-clamp experiments presented in this study, we have shown that expression of the cytoplasmic COOH-terminal 193 amino acids of murine polycystin-1 upregulated an ATP-induced Cl Ϫ current. The sIgPKD193 fusion construct was introduced in these cell lines under the influence of a Dex-responsive element; induction of sIgPKD193 fusion protein expression by treatment with Dex resulted in an increase in peak ATP-induced current and significantly prolonged the ATP response in the sIgPKD193 cell lines but had no effect on the ATP-induced current in control lines. In the absence of Dex, there was no difference in the ATP-induced currents between control and sIgPKD193 cell lines. Analysis of currentvoltage relationships demonstrated that the modu- lated current was mediated by Cl Ϫ . The current was completely and irreversibly inhibited by DIDS, consistent with involvement of a Ca 2ϩ -activated Cl Ϫ channel. UTP and ATP demonstrated similar concentrationresponse curves, and these responses were reversibly inhibited by PPADS, indicating that the ATP response was most probably the result of activation of P2Y 2 and/or P2Y 4 purinergic receptors. The involvement of these two P2Y subtypes is inferred by the following observations. The murine isoforms of both are activated by ATP and UTP (26, 34) . 2-meSATP and BzATP are partial agonists at the murine P2Y 2 receptor (10), but this subtype is relatively insensitive to PPADS, whereas murine P2Y 4 is particularly sensitive to this P2 receptor antagonist (34) . None of the other known P2Y receptor subtypes (23) fits the pharmacological profile of the endogenous P2Y receptor(s) in mouse M1 cells. In keeping with this interpretation, RT-PCR analysis of M1 parental cells showed expression of both P2Y 2 and P2Y 4 mRNA.
Expression of the sIgPKD193 fusion protein did not alter the agonist pharmacological profile of the response, indicating that the effect on ATP-stimulated Cl Ϫ conductance did not appear to be mediated through an alteration in the expression pattern of purinergic receptor subtypes. Expression of the fusion protein did not appear to have wider nonspecific effects on these cells, since the resting membrane potential, basal currents, and whole cell capacitance were similar in the two groups of cell lines.
Expression of the sIgPKD193 fusion protein increased the peak of the ATP response but also significantly slowed the recovery to baseline current after washout. As other investigators have shown (5), the effect of extracellular ATP on cell Ca 2ϩ is biphasic, with an early peak attributable to Ca 2ϩ release from the ER and a more sustained phase that is probably triggered by a subsequent period of Ca 2ϩ entry from the extracellular solution, termed the store-operated phase (30) . ATP-induced changes in cell Ca 2ϩ are responsible for the effect of ATP on Cl Ϫ channel activation (6, 9, 31) . We show in the present paper that the sIgPKD193 fusion protein-induced prolongation of ATP-induced Cl Ϫ current was probably the consequence of upregulation of store-operated Ca 2ϩ entry. The evidence for this was fourfold. entry pathway persisted to a lesser extent in the sIgPKD193 cells in the absence of Dex but was significantly increased by Dex treatment only in the sIgPKD193 cell lines. The persistence of the effect in the absence of Dex could be explained by background leak of fusion protein expression in noninduced cells (19) and was of insufficient magnitude to appreciably affect the current or cell Ca 2ϩ responses recorded in the absence of Dex in the single cell experiments.
Unexpectedly, although the peak amplitude of the whole cell current response was increased in cells expressing the sIgPKD193 fusion protein, we could detect no corresponding difference in the peak amplitude of the single-cell Ca 2ϩ responses. Thus there was no evidence, in our experimental model, for an effect of the sIgPKD193 fusion protein to increase ER Ca 2ϩ release. If ER release was not affected by the sIgPKD193 fusion protein, then the fusion protein might have upregulated the ATP-induced peak current through increased cell responsiveness to the initial phase of Ca 2ϩ release from the ER, but we have not addressed this issue in the current studies.
Aguiari et al.
(1) also found that expression of the truncated COOH-terminus of polycystin-1 in human embryonic kidney (HEK-293) cells increased the cell Ca 2ϩ response to ATP. However, in contrast to our findings, these authors concluded that the truncated fusion protein was increasing cell Ca 2ϩ responses via an effect on ER Ca 2ϩ release. This conclusion was based on parallel experiments in stably transfected HeLa cells treated with histamine, but the effect of the fusion protein on peak histamine-stimulated [Ca 2ϩ ] i , whether in the presence or absence of bath Ca 2ϩ , seemed marginal in the data presented by these authors. In fact, their figures showed that the truncated polycystin-1 fusion protein introduced a plateau to the ATP-induced Ca 2ϩ response in HEK cells and suggested that the fusion protein increased store-operated Ca 2ϩ entry induced by histamine in HeLa cells. We have directly demonstrated that the truncated polycystin-1 fusion protein augmented Ca 2ϩ entry after treatment with ATP in a well-characterized collecting ductderived cell line. Furthermore, we have established that this may represent a mechanism of disease, for the first time linking disturbance of polycystin pathways to the prolongation of an ATP-stimulated Cl Ϫ current. Aguiari et al. found that expression of the truncated polycystin-1 fusion protein increased the peak amplitude of Ca 2ϩ responses, whereas we found no such effect. Our single-cell studies were performed at room temperature, and those of Aguiari et al. were performed at 37°C; therefore, to exclude the possibility that the truncated polycystin-1 fusion protein might only increase the amplitude of Ca 2ϩ responses at the warmer temperature, we repeated a series of ATP- induced Ca 2ϩ responses at physiological temperatures. As seen in the original experiments, the cell Ca 2ϩ responses remained prolonged in cells expressing the PKD193 fusion protein studied at 34-36°C (the time taken for the decline from 80 to 20% of the peak response was 29 Ϯ 1.8 s in control vs. 38 Ϯ 3.2 s in PKD193-expressing cells, P ϭ 0.037, n ϭ 11 and n ϭ 16 respectively), and peak Ca 2ϩ responses were not increased in cells expressing the PKD193 fusion protein studied at the physiological temperature (fluorescence ratio: control 0.722 Ϯ 0.109, PKD193-expressing cells 0.561 Ϯ 0.117, n ϭ 11 and 16, respectively). We have no definitive explanation for the differences in peak responses between the two studies, but it is possible that the truncated polycystin fusion protein exhibits cell type-specific effects. Alternatively, this difference might have arisen from compartmentalization, since the bioluminescent protein aequorin (the Ca 2ϩ indicator used by Aguiari et al.) might not share the same cell distribution as the Ca 2ϩ indicator dye fluo 3. In any case, the peak Ca 2ϩ response is, at best, an indirect indicator of ER Ca 2ϩ release and might be influenced by other Ca 2ϩ fluxes arising from within or outside the cell.
In another recent study, Nauli et al. (27) described the cell Ca 2ϩ response to thrombin in distal renal tubule cells derived from a transgenic mouse with a targeted deletion of exon 34 of the PKD1 gene (25) . Interestingly, loss of polycystin-1 function in these cells resulted in an increased cell Ca 2ϩ response to thrombin, which was evident at the peak but also in the prolonged phase of the response, persisting for some 16 min after stimulation. Although these authors concluded that polycystin-1 was regulating Ca 2ϩ release from the ER, their data actually showed that removal of bath Ca 2ϩ brought the prolonged phase responses of control and transgenic cells together and caused a much greater reduction in the peak response of the transgenic cells compared with the controls. Loss of functional polycystin-1 therefore appeared to result in a greater dependency on external Ca 2ϩ , a finding very similar to our observations of the effect of the sIgPKD193 fusion protein. Therefore, the effects of the sIgPKD193 fusion protein described in the present study seem to indicate that the sIgPKD193 fusion protein acted as a dominant negative in the M1 cortical collecting duct cells, promoting increased store-operated Ca 2ϩ entry through inhibition of the function of native polycystin-1.
The pathophysiological significance of our findings may be assessed in the context of what is known of disease mechanisms in ADPKD. In ADPKD, the epithelial cells lining the cysts are derived from proximal and distal tubules, both of which usually function to reabsorb fluid from the tubule lumen. Clearly, for cyst expansion, fluid must be secreted in the cyst lumen at a rate that exceeds the rate of fluid reabsorption. In all secretory epithelia, fluid secretion is stimulated by increased intracellular cAMP or elevated cell Ca 2ϩ , acting on cystic fibrosis transmembrane conductance regulator (CFTR) or Ca 2ϩ -activated Cl Ϫ channels, respectively (16) . Even in typically reabsorptive renal tubular epithelia grown in tissue culture, fluid secretion can be activated by these stimuli, and there is some evidence that such pathways also exist in vivo (15) . However, the role of agonist-stimulated Cl Ϫ secretion in ADPKD is uncertain, and studies of cyst epithelia have not revealed any upregulation of CFTRmediated secretion compared with a variety of noncystic renal tubular epithelial cell lines (35) . Our data suggest that polycystin pathways may be involved in the regulation of fluid secretion in response to purinergic stimulation. This is a biologically plausible hypothesis, since all the components for purinergic pathway activation are present in the cyst environment (32) . Furthermore, there is increasing evidence that polycystin pathways are involved in the regulation of intracellular Ca 2ϩ homeostasis, perhaps modulating the activity of transient receptor potential-type channels that are thought to mediate store-operated Ca 2ϩ entry in eukaryotic cells (37, 40) .
How does the activity of the sIgPKD193 fusion protein relate to the function of full-length polycystin-1? Many other investigators have studied the activity of the truncated cytoplasmic COOH-terminus of polycystin-1. In such studies, some of the effects of the truncated fusion protein suggested that it might act like polycystin-1: induction of in-gel tubulogenesis, binding and activation of G␣ 1 (28, 29) . Others have shown effects suggesting interruption of the actions of polycystin-1: stabilization of ␤-catenin (22) , transformation of the cAMP growth phenotype from normal to polycystic (17, 36, 41) , and augmentation of ATP-stimulated Cl Ϫ secretion (19) . In other studies, the relationship to polycystin-1 pathways cannot be inferred easily, for example, activation of the transcription factor activator protein-1 (2), stabilization of RGS7 (21) , and induction of an oocyte cation conductance of uncertain origin (38) . Perhaps the manifestations of expression of the isolated COOH-terminus of polycystin-1 depend on the activity of endogenous pathways and the cell system examined. In our studies, expression of the sIgPKD193 fusion protein promoted a secretory phenotype, as would be predicted in cystic epithelia. Thus, in our experimental system, it appears that the fusion protein might have interrupted the function of the native fulllength polycystin-1 protein. This conclusion is strengthened by the data of Nauli et al. (27) , which appears to support a role for polycystin-1 in downregulating agonist-stimulated Ca 2ϩ entry. Our observations are the first to directly indicate that polycystin-1 pathways regulate agonist-stimulated Ca 2ϩ entry and provide, for the first time, a link between polycystin-1 and fluid secretion. Therefore, we propose that loss of functional polycystin-1 in ADPKD results in upregulation of store-operated Ca 2ϩ entry after a Ca 2ϩ release stimulus and that the subsequent activation of transepithelial Cl Ϫ secretion may play an important role in cyst development and expansion.
We thank Ian Spencer, Ariel Wolff, and Xiaoyu Zhang for assistance. 
DISCLOSURES

